POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW

POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW

HOLUBIAC Iulian Ștefan

Vlad Teodor GROSU

1. Alejandro, P., & Constantinescu, F. (2018). Review of Osteoporosis in the Older Adult: An Update. Rheumatic Diseases Clinics of North America, 44(3), 437-451.

2.Arron, J. R., & Choi, Y. (2000). Osteoimmunology: Bone versus immune system. Nature, 408(6812), 535-536.

3.Black, D. M., & Rosen, C. J. (2016). Postmenopausal Osteoporosis. The New England Journal of Medicine, 374(21), 2096-2097.

4. Bonewald, L. F. (2007). Osteocytes as Dynamic Multifunctional Cells. ANNALS of the New York Academy of Sciences, 1116, 281-290.

5. Boyce, B. F., & Xing, L. (2008). Functions of RANKL/RANK/OPG in bone modeling and remodeling. Archives of Biochemistry and Biophysics, 473(2), 139-146.

6. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., et al. (1998). osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev., 12(9), 1260-1268.

7. Burge, R., Dawson-Hughes, B., Solomon, D., Wong, J., King, A., & Tosteson, A. (2007). Incidence and economic burden of osteoporosis-related fractures in the United States 2005-2025. Journal of Bone and Mineral Research, 22, 465-475.

8. Carmen, G. (2005). Osteoporoza - fiziopatologie, diagnostic, tratament. Cluj-Napoca: Risoprint.

9. Cauley, J. A. (2015). Estrogen and bone health in men and women. Steroids, 99, 11-15.

10. Chen, C., Cheng, P., Xie, H., Zhou, H.-D., Wu, X.-P., Liao, E.-Y., et al. (2014). MiR-503 Regulates Osteoclastogenesis via Targeting RANK. Journal of Bone and Mineral Research, 29(2), 338-347.

11. Cheng, P., Chen, C., He, H.-B., Hu, R., Zhou, H.-D., Xie, H., et al. (2013). miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. Journal of Bone and Mineral Research, 28(5), 1180-1190.

12. Clarke, B. L., & Khosla, S. (2010). Physiology of Bone Loss. Radiologic Clinics, 48(3), 483-495.

13. Cooper, C., Cole, Z. A., Holroyd, C. R., Earl, S. C., Harvey, N. C., Dennison, E. M., et al. (2011). Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporosis International, 22, 1277-1288.

14. Costa, A. L., Silva, M. A., Brito, L. M., Nascimento, A. C., Barbosa, M. d., Batista, J. E., et al. (2016). Osteoporosis in primary care: an opportunity to approach risk factors. Revista Brasileira de Reumatologia English Edition, 56(2), 111-116.

15. David, S., Jackie, B., & Lewis, R. (2012). Hole's Essentials of Human Anatomy & Physiology 11th edition. New York: The McGraw-Hill Companies.

16. Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003). Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. The Journal of Clinical Investigation, 111, 1221-1230.

17. Ego, S. (2003). Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporosis International, 14(3), 2-8.

18. Gallangher, J. C., Young, M. M., & Nordin, B. E. (1972). EFFECTS OF ARTIFICIAL MENOPAUSE ON PLASMA AND URINE CALCIUM AND PHOSPHATE. Clinical Endocrinology, 1, 57-64.

19. Garnero, D. P., Sornay-Rendu, E., Chapuy, M.-C., & Delmas, P. D. (1996). Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Journal of Bone and Mineral Research, 11, 337-349.

20. Gauthier, A., Kanis, J. A., Jiang, Y., Martin, M., Compston, J. E., Borgström, F., et al. (2011). Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model. Archives of Osteoporosis, 6(1-2), 179-188.

21. Gennari, C., Agnusdei, D., Nardi, P., & Civitelli, R. (1990). Estrogen preserves a normal intestinal responsiveness to 1,25-dihidroxyvitamin D3 in oophorectomized women. The Journal of Clinical Endocrinology & Metabolism, 71, 1288-1293.

22. Guyton, A. C., & Hall, J. E. (2006). Textbook of Medical Physiology. Philadelphia: Elsevier Inc.

23. Ha, H., Kwak, H. B., Lee, S. W., Jin, H. M., Kim, H.-M., Kim, H.-H., et al. (2004). Reactive oxygen species mediate RANK signaling in osteoclasts. Experimental Cell Research, 301(2), 119-127.

24.Hanada, R., Hanada, T., Sigl, V., Schramek, D., & Penninger, J. M. (2011). RANKL/RANK-beyond bones. Journal of Molecular Medicine, 89(7), 647-656.

25. Heaney, R. P. (2000). Peak bone mass. Osteoporosis International, 11(12), 985-1009.

26. Heaney, R. P., Abrams, S., Dawson-Hughes, B., Looker, A., Marcus, R., Matkovic, V., et al. (2000). Peak bone mass. Osteoporosis International, 11(12), 985-1009.

27. Henriquez, S., & Romero, M. J. (2018). Osteoporosis. Medicine - Programa de Formación Médica Continuada Acreditado, 12(60), 3499-3505.

28. Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000). The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption. Journal of Bone and Mineral Research, 15(1), 2-12.

29. Hou, Y.-C., Wu, C.-C., Liao, M.-T., Shyu, J.-F., Hung, C.-F., Yen, T.-H., et al. (2018). Role of nutritional vitamin D in osteoporosis treatment. Clinica Chimica Acta, 484, 179-191.

30. Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., et al. (1999). Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proceedings of the National Academy of Sciences of the United States of America, 96(7), 3540-3545.

31. Ichinose, Y., Tanaka, H., Inoue, M., Mochizuki, S., Tsuda, E., & Seino, Y. (2004). Osteoclastogenesis Inhibitory Factor/Osteoprotegerin Reduced Bone Loss Induced by Mechanical Unloading. Calcified Tissue International, 75(4), 338-343.

32. International Osteoporosis Foundation. (2015). Osteoporosis & Musculoskeletal disorders. Retrieved Noiembrie 5, 2017, from IOF International: https://www.iofbonehealth.org/what-is-osteoporosis

33. Jaul, E., & Barron, J. (2017). Age-related diseases and clinical and public health implications for the 85 years old and over population. Frontiers in Public Health, 5, 335.

34. Kanis, J. A., Burlet, N., C.Cooper, Delmas, P. D., Reginster, J. Y., Borgstrom, F., et al. (2008). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 19(4), 399-428.

35. Khosla, S., Atkinson, E. J., III, L. J., & Riggs, B. L. (1997). Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study. The Journal of Clinical Endocrinology & Metabolism, 82(5), 1522-1527.

36. Kostenuik, P. J. (2005). Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength, 5(6), 618-625.

37. Lai, C.-L., Tseng, S.-Y., Chen, C.-N., Hsu, P.-S., Liao, W.-C., Wang, C.-H., et al. (2013). Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: A randomized controlled trial. Clinical Intervention in Aging, 8, 1603-1609.

38. Lanzillotti, H. S., Lanzillotti, R. S., Trotte, A. P., Dias, A. S., Bornand, B., & Costa, E. A. (2003). Osteoporose em mulheres na pós-menopausa, cálcio dietético e outros fatores de risco. Revista de Nutrição, 16, 181-193.

39.Lau, R. Y.-c., & Guo, X. (2011). A Review on Current Osteoporosis Research: With Special Focus on Disuse Bone Loss. Journal of Osteoporosis.

40. Li, C.-J., Cheng, P., Liang, M.-K., Chen, Y.-S., Lu, Q., Wang, J.-Y., et al. (2015). MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. The Journal of Clinical Investigation, 125(4), 1509-1522.

41. Li, R., Liang, L., Dou, Y., Huang, Z., Mo, H., Wang, Y., et al. (2015). Mechanical Strain Regulates Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. BioMed Research International.

42. Marieb, E. N., Wilhelm, P. B., & Mallatt, J. B. (2014). Bones and skeletal tissues. In Human Anatomy, 7th edition (pp. 123-149). USA: Pearson Education.

43. McKane, W. R., Khosla, S., Burritt, M. F., Kao, P. C., Wilson, D. M., Ory, S. J., et al. (1995). Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study. The Journal of Clinical Endocrinology & Metabolism, 80(12), 3458-3464.

44. Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., et al. (1998). Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin. Biochemical and Biophysical Research Communications, 247(3), 610-615.

45. Monzur, M., Dympna, H., Jose, L. M., Marc, D. M., & Gerard, K. (2005). Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes & Development, 19, 1093-1104.

46. Nakamura, T., Y, I., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., et al. (2007). Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell, 811-823.

47. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Ohhora, M., Feng, J. Q., et al. (2011). Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Medicine, 17(10), 1231-1234.

48. Phipps,   R.,  Mitlak,   B.   H.,   Burr,   D.  B.,   &   Allen,   M.   R.   (2019). Pharmaceutical Treatments of Osteoporosis. In D. B. Burr, & M. Allen, Basic   and   Applied   Bone   Biology   (pp.   389-410). Indianapolis: Academic Press.

49. Qiu, C., Chen, H., Wen, J., Zhu, P., Lin, F., Huang, B., et al. (2013). Associations Between Age at Menarche and Menopause With Cardiovascular Disease, Diabetes, and Osteoporosis in Chinese Women. The Journal of Clinical Endocrinology & Metabolism, 98(4), 1612-1621.

50.Riggs, B. L., Khosla, S., & Melton, L. J. (2002). Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews, 23, 279-302.

51. Riggs, B. L., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Peterson, J. M., et al. (2004). Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites. Journal of Bone and Mineral Research, 19(12), 1945-1954.

52. Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., Melton, L. J. (1981). Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. The Journal of Clinical Investigation, 67(2), 328-335.

53. Rizzoli, R. (2010). Atlas of Postmenopausal Osteoporosis Third Edition. Geneva: Current Medicine Group.

54. Rochefort, G. Y., Pallu, S., & Benhamou, C. L. (2010). Osteocyte: the unrecognized side of bone tissue. Osteoporosis International, 21(9), 1457-1469.

55. Ross, A., Bateman, T., Kostenuik, P., Ferguson, V., Lacey, D., & Dunstan, C. (2001). The effects of osteoprotegerin on the mechanical properties of rat bone. J Mater Sci Mater Med, 12(7), 583-588.

56. Sevgi, B. R., & Duong, L. T. (2008). Cathepsin K – A New Molecular Target for Osteoporosis. IBMS BoneKEy, 5(1), 16-24.

57. Shen, C. L., Chyu, M. C., & Wang, J. S. (2013). Tea and bone health: steps forward in translational nutrition. The American Journal of Clinical Nutrition, 98(6), 1694S-1699S.

58. Silva, H. G., Mendonca, L. M., Conceicao, F. L., Zahar, S. E., & Farias, M. L. (2007). Influence of obesity on bone density in postmenopausal women. Arquivos Brasileiros de Endocrinologia & Metabologia, 51(6), 943-949.

59. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., et al. (1997). Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density. Cell, 89(2), 309-319.

60. Streicher, C., Heyny, A., Andrukhova, O., Haigl, B., Slavic, S., Schuler, C., et al. (2017). Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells. Scientific Reports 7, 6460.

61. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999). Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families. Endocrine Reviews, 20(3), 345-347.

62. Sundeep Khosla, L. J. (2011). The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed? Journal of Bone and Mineral Research, 26, 441-451.

63. Svejme, O., Ahlborg, H. G., Nilsson, J.-A., & Karlsson, M. K. (2013). Low BMD is an independent predictor of fracture and early menopause of mortality in post-menopausal women – A 34-year prospective study. Maturitas, 74(4), 341-345.

64. Svejme, O., Ahlborg, H., Nilsson, J.-A., & Karlsson, M. (2012). Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women. BJOG, 119(7), 810-816.

65. Thompson, W. R., Rubin, C. T., & Rubin, J. (2012). Mechanical regulation of signaling pathways in bone. Gene, 503, 179-193.

66. Tortora, G. J., & Derrickson, B. H. (2012). The skeletal system. In Principles of Anatomy and Physiology, 13th edition (pp. 182-207). USA: John Wiley & Sons.

67. Villiers, T. J. (2009). Bone health and osteoporosis in postmenopausal women. Best Practice & Research Clinical Obstetrics and Gynaecology, 23, 73-85.

68. Wada,  T.,  Nakashima,  T.,  Hiroshi,  N.,  &  Penninger,  J.  M.  (2006). RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends in Molecular Medicine, 12(1), 17-25.

69. Wade, S. W., Strader, C., Fitzpatrick, L. A., Anthony, M. S., & O`Malley, C. D. (2014). Estimating prevalence of osteoporosis: examples from industrialized countries. Archives of Osteoporosis, 9(182).

70. Weber-Rajek, M., Mieszkowski, J., Niespodzinski, B., & Ciechanowska, K. (2015). Whole-body vibration exercise in postmenopausal osteoporosis. Prz Menopauzalny, 14(1), 41-47.

71. Weitzmann, M. N. (2013). The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica.

72. Wright, H. L., McCarthy, H. S., Middleton, J., & Marshall, M. J. (2009). RANK, RANKL and osteoprotegerin in bone biology and disease. Current Reviews in Musculoskeletal Medicine, 2(1), 56-64.

73. Yang, L., Cheng, P., Chen, C., He, H.-B., Xie, G.-Q., Zhou, H.-D., et al. (2012). miR-93/Sp7 function loop mediates osteoblast mineralization. Journal of Bone and Mineral Research, 27(7), 1598-1606.